BIOCEPT INC - 09072V105
Detailed investor-level table based on 13F positions.
Early Q2 2014 data: only 4 institutional holders reported so far. The full shareholder list will grow as more funds file with the SEC.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| GARRISON BRADFORD & ASSOCIATES INC | History | New | 156,400 | 1,148 | 1.11% | — | 1 | +156,400 | New | Q1 2014 | May 14, 2014 |
| LMR Partners LLP | History | New | 90,968 | 668 | 0.09% | — | 2 | +90,968 | New | Q1 2014 | Apr 25, 2014 |
| PERKINS CAPITAL MANAGEMENT INC | History | New | 89,450 | 657 | 0.46% | — | 3 | +89,450 | New | Q1 2014 | May 07, 2014 |
| Verition Fund Management LLC | History | New | 80,483 | 591 | 0.09% | — | 4 | +80,483 | New | Q1 2014 | May 14, 2014 |
| VANGUARD GROUP INC | History | New | 27,865 | 205 | 0.0% | — | 5 | +27,865 | New | Q1 2014 | May 13, 2014 |
| UBS AG | History | New | 707 | 5 | 0.0% | — | 6 | +707 | New | Q1 2014 | May 16, 2014 |
| MORGAN STANLEY | History | New | 208 | 2 | 0.0% | — | 7 | +208 | New | Q1 2014 | May 13, 2014 |
| WELLS FARGO & COMPANY/MN | History | New | 125 | 1 | 0.0% | — | 8 | +125 | New | Q1 2014 | May 15, 2014 |
| CITIGROUP INC | History | New | 8 | 0 | — | — | — | +8 | New | Q1 2014 | May 15, 2014 |